Physician profile
Jonathan D Couch
NPI 1689808107
$3,699.05
in general payments reported to CMS, 2019-2025
46 companies · $150 in 2025
The $150 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $907 · 2020: $336 · 2021: $113 · 2022: $1,018 · 2023: $1,140 · 2024: $35.04 · 2025: $150.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,326.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,325.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $583.02 | 2021-2023 | Ubrelvy, Botox, Duopa |
| Medtronic, INC. | $356.82 | 2022-2025 | Mazor X System |
| Amgen INC. | $277.65 | 2019-2023 | Evenity, Prolia |
| Si-Bone, INC. | $184.59 | 2019-2020 | |
| Alexion Pharmaceuticals, INC. | $178.97 | 2019-2023 | Soliris, Ultomiris |
| Sunovion Pharmaceuticals INC. | $176.37 | 2019-2022 | |
| Neurocrine Biosciences, INC. | $175.37 | 2019-2023 | Ongentys, Ingrezza |
| Livanova USA, INC. | $131.89 | 2019-2023 | Vns Therapy Sentiva Model 1000 Generator |
| Biohaven Pharmaceutical Holding Company Ltd. | $129.17 | 2022 | |
| Avanir Pharmaceuticals, INC. | $127.27 | 2019-2022 | |
| Zimmer Biomet Holdings, INC. | $113.95 | 2019-2022 | |
| Grifols USA, LLC | $95.65 | 2019-2022 | |
| Medtronic USA, INC. | $91.51 | 2019 | |
| Lundbeck LLC | $81.95 | 2019-2023 | Vyepti |
| Inspire Medical Systems, INC. | $76.06 | 2024-2025 | Inspire |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Couch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.